HASHEM EL-SERAG to Confidence Intervals
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Confidence Intervals.
Connection Strength
0.484
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
Score: 0.105
-
Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
Score: 0.100
-
Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes. Am J Gastroenterol. 2009 May; 104(5):1241-8.
Score: 0.076
-
Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008 Feb 15; 167(4):377-89.
Score: 0.069
-
Ethnic variations in the occurrence of gastroesophageal cancers. J Clin Gastroenterol. 1999 Mar; 28(2):135-9.
Score: 0.038
-
Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp Clin Trials. 2012 May; 33(3):523-33.
Score: 0.023
-
Barrett's esophagus in children and adolescents without neurodevelopmental or tracheoesophageal abnormalities: a prospective study. Gastrointest Endosc. 2011 May; 73(5):875-80.
Score: 0.022
-
Complications of pediatric colonoscopy: a five-year multicenter experience. Clin Gastroenterol Hepatol. 2008 May; 6(5):515-20.
Score: 0.018
-
Racial disparities in utilization of liver transplantation for hepatocellular carcinoma in the United States, 1998-2002. Am J Gastroenterol. 2008 Jan; 103(1):120-7.
Score: 0.017
-
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007 Apr; 5(4):508-12.
Score: 0.016